A Prospective, Multicenter Clinical Study of Hetrombopag in the Prevention of Thrombocytopenia Caused by Lung Cancer Therapy
Clinical trial NCT07101627 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07101627
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2027-04-30
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.